Manufacturers

Bhat Bio-tech India (P) Ltd.

No. 11-A, 4th Cross, Veerasandra, Industrial Area , 560 100 Electronics City, Bangalore
India

Telephone +91 80 33194000
Fax +91 80 33194001
bhatbiotech@gmail.com

Trade fair hall

  • Hall 1 / A40
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 1): stand A40

Fairground map

MEDICA 2016 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.02  DNA diagnosis kits

Our products

Product category: DNA diagnosis kits

PAREEKSHAK® HIV-1/2 SPOT TEST

PAREEKSHAK® HIV-1/2 Spot is an immunoconcentration based assay for the qualitative detection of antibodies to HIV-1 & HIV-2 in Human Serum or Plasma.

SALIENT FEATURES
◾ Rapid visual Test based on immunococentration technology.
◾ Detects HIV-1 & HIV-2 antibodies in Plasma/Serum.
◾ Use of HIV-1 gp41 & C terminal of gp120 for HIV-1 & gp36 antigen for HIV-2.
◾ Shelf life of 18 months when stored at 2-80 C.
◾ Results within 5 minutes.
◾ In built control dot.
◾ No instrument required.
◾ Sensitivity above 99.5% & Specificity above 99%

More Less

About us

Company details

Leading the way in affordable quality healthcare

Bhat Bio-Tech India Private Limited (BBI) commenced operations in 1994 in Bangalore, as the entrepreneurial endeavor of a group of NRIs from USA, spearheaded by Dr. Shama Bhat, an internationally acclaimed scientist. What began then as a determined attempt to bring affordable yet top quality diagnostic kits and biotechnological products into emerging markets, has today grown into one of the rapidly expanding and niche diagnostic & biotech companies in the country.

Founder, Chairman and Managing Director

The promoter of Bhat Bio-tech India Private Limited (BBI), Dr. Shama Bhat, has leveraged his 35 years of rich experience in R&D and manufacturing in the Biotechnology area, to conceive this enterprise. An alumnus of Kasturba Medical College, Manipal and the Indian Institute of Science, Bangalore, Dr. Shama Bhat is trained at the University of Connecticut Health Center, Farmington, USA. Dr. Bhat strengthened the faculty of the Neurology Department, University of Pennsylvania, Philadelphia, USA from 1983 to 1994. His discovery of Galactosyl Ceramide, as an alternative receptor for HIV in neural cells, won him both universal acclaim as well as the undivided attention of scientific circles, the world over. Dr. Bhat has over forty publications to his credit and is a recipient of the prestigious Ranbaxy Award.

Corporate Vision and Mission

The vision shared at BBI is the continued development of company with a global reach, capable of penetrating each market, fueled by a constant flow of quality products, which provide innovative and affordable solution to customers. Bhat Bio-Tech's Mission is to establish a company for Diagnostics, Molecular Diagnostics, Drug Discovery, Bio-Pharmaceuticals and Biotechnology based products for industry and healthcare. The products should be affordable to common man in India and elsewhere in the world.

Global Footprint

Consolidating its position as India's niche and prominently acknowledged Diagnostic and Biotech Company, BBI has expanded operations to include several promising markets overseas effectively. Today, BBI exports to over 30 countries across the North America, UK, South Asia, Middle East, Central America, South America, South Africa and South East Asia.

 

More Less

Company data

Sales volume

1-9 Mio US $

Export content

max. 25%

Number of employees

100-499

Foundation

1994

Area of business

Diagnostics